Skip to content
memoinOncology Logo memoinOncology Logo memoinOncology Logo
  • CONGRESS REPORTS
    • Solid Tumors
      • ASCO
      • EANM
      • ESMO
      • ESMO IO
    • Hematology
      • ASH
      • EHA
      • ESH CLL
      • ISHL
      • iwWM
    • Lung Cancer
      • ASCO
      • CSCO
      • ECC
      • ELCC
      • ESMO
      • ESMO Asia
      • WCLC
  • MEDICAL EDUCATION
    • Clinical Trials
    • Preceptorship reports
    • Articles
  • COLLABORATIONS
    • CSCO
    • LACOG
    • SEO
    • SSO
  • SUPPORTER
    • Boehringer Ingelheim in Oncology
    • BeiGene
    • ITM
  • MORE…
    • ABOUT US
    • LINKS
    • CALENDAR
    • VIDEOS

Real-world risk assessment, outcomes and adoption of novel drugs in CLL patients: insights from US databases

Real-world risk assessment, outcomes and adoptio

Read More

Promising novel approaches in various B-cell malignancies

Promising novel approaches in various B-cell mal

Read More

Phase II data on novel BTK inhibitors for patients with Waldenström’s macroglobulinemia

Phase II data on novel BTK inhibitors for patien

Read More

Marginal zone lymphoma: PI3Kδ inhibition and beyond

Marginal zone lymphoma: PI3Kδ inhibition and bey

Read More

Mantle cell lymphoma: refining clinical outcomes beyond the current boundaries

Mantle cell lymphoma: refining clinical outcomes

Read More

Management of patients with relapsed/refractory CLL: what is new?

Management of patients with relapsed/refractory

Read More

Determining first-line CLL/SLL treatment strategies with optimized efficacy and safety

Determining first-line CLL/SLL treatment strateg

Read More

Preface

Preface – ASH 2021 Amitkumar Mehta, MD, Di

Read More

Sponsors:
This website is intended only for healthcare professionals outside the US, the UK, and Australia   |   This website is supported by an unrestricted medical education grant from BeiGene, Boehringer Ingelheim and ITM
© Copyright 2012 -  memoinOncology BY SPRINGER-VERLAG GmbH   |   Projekt: infill healthcare communication GmbH.   |   Alle Rechte vorbehalten.   |   Die Nutzung der Inhalte ist ausschließlich für den privaten Gebrauch bestimmt. Die über den persönlichen Gebrauch hinausgehende Vervielfältigung und Verbreitung ist nicht gestattet.
Impressum   |   Datenschutzerklärung   |   AGB   |   Kontakt   |   Cookie Einstellungen

Accessibility by WAH